Sun exposure and vitamin D are independent risk factors for CNS demyelination
- PMID: 21300969
- DOI: 10.1212/WNL.0b013e31820af93d
Sun exposure and vitamin D are independent risk factors for CNS demyelination
Abstract
Objectives: To examine whether past and recent sun exposure and vitamin D status (serum 25-hydroxyvitamin D [25(OH)D] levels) are associated with risk of first demyelinating events (FDEs) and to evaluate the contribution of these factors to the latitudinal gradient in FDE incidence in Australia.
Methods: This was a multicenter incident case-control study. Cases (n = 216) were aged 18-59 years with a FDE and resident within one of 4 Australian centers (from latitudes 27°S to 43°S), from November 1, 2003, to December 31, 2006. Controls (n = 395) were matched to cases on age, sex, and study region, without CNS demyelination. Exposures measured included self-reported sun exposure by life stage, objective measures of skin phenotype and actinic damage, and vitamin D status.
Results: Higher levels of past, recent, and accumulated leisure-time sun exposure were each associated with reduced risk of FDE, e.g., accumulated leisure-time sun exposure (age 6 years to current), adjusted odds ratio (AOR) = 0.70 (95% confidence interval [CI] 0.53-0.94) for each ultraviolet (UV) dose increment of 1,000 kJ/m(2) (range 508-6,397 kJ/m(2)). Higher actinic skin damage (AOR = 0.39 [95% CI 0.17-0.92], highest grade vs the lowest) and higher serum vitamin D status (AOR = 0.93 [95% CI 0.86-1.00] per 10 nmol/L increase in 25(OH)D) were independently associated with decreased FDE risk. Differences in leisure-time sun exposure, serum 25(OH)D level, and skin type additively accounted for a 32.4% increase in FDE incidence from the low to high latitude regions.
Conclusions: Sun exposure and vitamin D status may have independent roles in the risk of CNS demyelination. Both will need to be evaluated in clinical trials for multiple sclerosis prevention.
Comment in
-
Multiple sclerosis: sun exposure and vitamin D, ultra-high-field imaging, and B cell clones in the meninges.J Neurol. 2011 Apr;258(4):708-10. doi: 10.1007/s00415-011-6000-6. J Neurol. 2011. PMID: 21431894 No abstract available.
-
Sun exposure and vitamin D are independent risk factors for CNS demyelination.Neurology. 2011 Oct 4;77(14):1405; author reply 1405-6. doi: 10.1212/WNL.0b013e3182294610. Neurology. 2011. PMID: 21968847 No abstract available.
Similar articles
-
Latitudinal variation in incidence and type of first central nervous system demyelinating events.Mult Scler. 2010 Apr;16(4):398-405. doi: 10.1177/1352458509359724. Epub 2010 Feb 18. Mult Scler. 2010. PMID: 20167594
-
Validity and reliability of adult recall of past sun exposure in a case-control study of multiple sclerosis.Cancer Epidemiol Biomarkers Prev. 2006 Aug;15(8):1538-44. doi: 10.1158/1055-9965.EPI-05-0969. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16896046
-
Associations between silicone skin cast score, cumulative sun exposure, and other factors in the ausimmune study: a multicenter Australian study.Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):2887-94. doi: 10.1158/1055-9965.EPI-09-0191. Epub 2009 Oct 20. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19843682
-
The challenge resulting from positive and negative effects of sunlight: how much solar UV exposure is appropriate to balance between risks of vitamin D deficiency and skin cancer?Prog Biophys Mol Biol. 2006 Sep;92(1):9-16. doi: 10.1016/j.pbiomolbio.2006.02.010. Epub 2006 Feb 28. Prog Biophys Mol Biol. 2006. PMID: 16603232 Review.
-
Is hypovitaminosis D one of the environmental risk factors for multiple sclerosis?Brain. 2010 Jul;133(Pt 7):1869-88. doi: 10.1093/brain/awq147. Brain. 2010. PMID: 20584945 Review.
Cited by
-
Assessment of vitamin D status and associated risk factors in high-altitude populations affected by multiple sclerosis: A case-control study.Medicine (Baltimore). 2024 May 31;103(22):e38369. doi: 10.1097/MD.0000000000038369. Medicine (Baltimore). 2024. PMID: 39259102 Free PMC article.
-
Multiple sclerosis and abnormal spermatozoa: A bidirectional two-sample mendelian randomization study.PLoS One. 2024 Aug 20;19(8):e0308815. doi: 10.1371/journal.pone.0308815. eCollection 2024. PLoS One. 2024. PMID: 39163298 Free PMC article.
-
Causal associations between 25-hydroxyvitamin D levels and NMOSD: a two-Sample Mendelian randomization analysis.Neurol Sci. 2024 May;45(5):2379-2381. doi: 10.1007/s10072-023-07290-x. Epub 2024 Jan 4. Neurol Sci. 2024. PMID: 38175315 No abstract available.
-
Vitamin D did not reduce multiple sclerosis disease activity after a clinically isolated syndrome.Brain. 2024 Apr 4;147(4):1206-1215. doi: 10.1093/brain/awad409. Brain. 2024. PMID: 38085047 Free PMC article. Clinical Trial.
-
Environmental risk factors of multiple sclerosis in the Middle East and North Africa region: A systematic review.Curr J Neurol. 2021 Jul 6;20(3):166-184. doi: 10.18502/cjn.v20i3.7693. Curr J Neurol. 2021. PMID: 38011462 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous